PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
Go back to PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers| (NASDAQ: PRTC) | Delayed: 17.42 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.42 | 52 Week High | $ | |||
| Open | $17.42 | 52 Week Low | $ | |||
| Day High | $17.42 | P/E | N/A | |||
| Day Low | $17.42 | EPS | $ | |||
| Volume | 489 | |||||
| (NASDAQ: SPTX) | Delayed: 24.37 +0.76 (3.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.61 | 52 Week High | $ | |||
| Open | $23.66 | 52 Week Low | $ | |||
| Day High | $25.03 | P/E | N/A | |||
| Day Low | $23.65 | EPS | $ | |||
| Volume | 49,161 | |||||
